部分实性腺癌肿瘤大小的影像学巩固对生存的影响——倾向评分匹配分析。

IF 1.7 4区 医学 Q4 ONCOLOGY
Haruaki Hino, Natsumi Maru, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Katsuyasu Kouda, Tomohiro Murakawa
{"title":"部分实性腺癌肿瘤大小的影像学巩固对生存的影响——倾向评分匹配分析。","authors":"Haruaki Hino, Natsumi Maru, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Katsuyasu Kouda, Tomohiro Murakawa","doi":"10.21873/anticanres.17739","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Recent evidence indicates that the radiographical consolidation tumor size of part-solid adenocarcinomas does not have prognostic value unlike that of pure-solid adenocarcinomas. We analyzed the impact of consolidation tumor size on postoperative survival in patients with part-solid adenocarcinoma.</p><p><strong>Patients and methods: </strong>This retrospective study analyzed data of 375 patients with part-solid adenocarcinomas who underwent surgery at our Institute between 2006 and 2021. The consolidation-to-tumor ratio (CTR) was determined using preoperative computed tomography and the patients were grouped into groups with low (0-≤0.5, n=187) or high (>0.5 to <1, n=188) CTR. Clinical characteristics and survival were analyzed using propensity score-matching for radiographical consolidation tumor size.</p><p><strong>Results: </strong>A larger radiographical consolidation tumor size significantly correlated with higher CTR (r<sup>2</sup>=0.56, <i>p</i><0.0001) and larger pathological invasive size (r<sup>2</sup>=0.41, <i>p</i><0.0001). Male sex and high radiographical consolidation tumor size were significant negative risk factors for overall survival in the unmatched cohort. The 5-year overall survival rates in the low- and high-CTR groups were 95.2% <i>versus</i> 85.2% (<i>p</i>=0.008) in the unmatched cohort, and 93.0% <i>versus</i> 83.2% (<i>p</i>=0.10) in the matched cohort. Competing-risk analysis showed 5-year cumulative incidence of cancer-specific death were 0% [95% confidence interval (CI)=not estimable] and 5.57% (95% CI=2.10-11.70%) in the low- and high-CTR groups, respectively (<i>p</i>=0.01), in contrast, the corresponding rates of non-cancer-related death were 4.72% (95% CI=1.40-11.10%) and 9.44% (95% CI=4.50-16.50%), respectively (<i>p</i>=0.18). These results indicate that survival of patients with consolidation-dominant part-solid adenocarcinoma is poor due to a higher rate of lung cancer death.</p><p><strong>Conclusion: </strong>The radiographical consolidation tumor size may affect overall survival and possibly reflect tumor growth activity, being consistent with 8<sup>th</sup> edition of the TNM classification in that larger consolidation tumor size significantly correlates with poor survival.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 9","pages":"3795-3807"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Radiographical Consolidation of Tumor Size of Part-solid Adenocarcinomas on Survival - A Propensity Score-matching Analysis.\",\"authors\":\"Haruaki Hino, Natsumi Maru, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Katsuyasu Kouda, Tomohiro Murakawa\",\"doi\":\"10.21873/anticanres.17739\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Recent evidence indicates that the radiographical consolidation tumor size of part-solid adenocarcinomas does not have prognostic value unlike that of pure-solid adenocarcinomas. We analyzed the impact of consolidation tumor size on postoperative survival in patients with part-solid adenocarcinoma.</p><p><strong>Patients and methods: </strong>This retrospective study analyzed data of 375 patients with part-solid adenocarcinomas who underwent surgery at our Institute between 2006 and 2021. The consolidation-to-tumor ratio (CTR) was determined using preoperative computed tomography and the patients were grouped into groups with low (0-≤0.5, n=187) or high (>0.5 to <1, n=188) CTR. Clinical characteristics and survival were analyzed using propensity score-matching for radiographical consolidation tumor size.</p><p><strong>Results: </strong>A larger radiographical consolidation tumor size significantly correlated with higher CTR (r<sup>2</sup>=0.56, <i>p</i><0.0001) and larger pathological invasive size (r<sup>2</sup>=0.41, <i>p</i><0.0001). Male sex and high radiographical consolidation tumor size were significant negative risk factors for overall survival in the unmatched cohort. The 5-year overall survival rates in the low- and high-CTR groups were 95.2% <i>versus</i> 85.2% (<i>p</i>=0.008) in the unmatched cohort, and 93.0% <i>versus</i> 83.2% (<i>p</i>=0.10) in the matched cohort. Competing-risk analysis showed 5-year cumulative incidence of cancer-specific death were 0% [95% confidence interval (CI)=not estimable] and 5.57% (95% CI=2.10-11.70%) in the low- and high-CTR groups, respectively (<i>p</i>=0.01), in contrast, the corresponding rates of non-cancer-related death were 4.72% (95% CI=1.40-11.10%) and 9.44% (95% CI=4.50-16.50%), respectively (<i>p</i>=0.18). These results indicate that survival of patients with consolidation-dominant part-solid adenocarcinoma is poor due to a higher rate of lung cancer death.</p><p><strong>Conclusion: </strong>The radiographical consolidation tumor size may affect overall survival and possibly reflect tumor growth activity, being consistent with 8<sup>th</sup> edition of the TNM classification in that larger consolidation tumor size significantly correlates with poor survival.</p>\",\"PeriodicalId\":8072,\"journal\":{\"name\":\"Anticancer research\",\"volume\":\"45 9\",\"pages\":\"3795-3807\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anticancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/anticanres.17739\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17739","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:最近的证据表明,部分实性腺癌的x线实变肿瘤大小不像纯实性腺癌那样具有预后价值。我们分析了实变肿瘤大小对部分实性腺癌患者术后生存的影响。患者和方法:本回顾性研究分析了2006年至2021年在我院接受手术的375例部分实体性腺癌患者的数据。通过术前计算机断层扫描确定实变与肿瘤比(CTR),并将患者分为低(0-≤0.5,n=187)和高(>0.5)组。结果:较大的放射学实变肿瘤大小与较高的CTR显著相关(r2=0.56, p2=0.41,未匹配队列为85.2% (p=0.008),匹配队列为93.0%对83.2% (p=0.10)。竞争风险分析显示,低ctr组和高ctr组的5年累积癌症特异性死亡发生率分别为0%[95%可信区间(CI)=不可估计]和5.57% (95% CI=2.10-11.70%) (p=0.01),而相应的非癌症相关死亡发生率分别为4.72% (95% CI=1.40-11.10%)和9.44% (95% CI=4.50-16.50%) (p=0.18)。这些结果表明,由于肺癌死亡率较高,以实变为主的部分实性腺癌患者的生存率较低。结论:实变肿瘤的影像学大小可能影响总体生存,并可能反映肿瘤的生长活性,与第8版TNM分级一致,实变肿瘤的大小越大,生存率越差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of Radiographical Consolidation of Tumor Size of Part-solid Adenocarcinomas on Survival - A Propensity Score-matching Analysis.

Background/aim: Recent evidence indicates that the radiographical consolidation tumor size of part-solid adenocarcinomas does not have prognostic value unlike that of pure-solid adenocarcinomas. We analyzed the impact of consolidation tumor size on postoperative survival in patients with part-solid adenocarcinoma.

Patients and methods: This retrospective study analyzed data of 375 patients with part-solid adenocarcinomas who underwent surgery at our Institute between 2006 and 2021. The consolidation-to-tumor ratio (CTR) was determined using preoperative computed tomography and the patients were grouped into groups with low (0-≤0.5, n=187) or high (>0.5 to <1, n=188) CTR. Clinical characteristics and survival were analyzed using propensity score-matching for radiographical consolidation tumor size.

Results: A larger radiographical consolidation tumor size significantly correlated with higher CTR (r2=0.56, p<0.0001) and larger pathological invasive size (r2=0.41, p<0.0001). Male sex and high radiographical consolidation tumor size were significant negative risk factors for overall survival in the unmatched cohort. The 5-year overall survival rates in the low- and high-CTR groups were 95.2% versus 85.2% (p=0.008) in the unmatched cohort, and 93.0% versus 83.2% (p=0.10) in the matched cohort. Competing-risk analysis showed 5-year cumulative incidence of cancer-specific death were 0% [95% confidence interval (CI)=not estimable] and 5.57% (95% CI=2.10-11.70%) in the low- and high-CTR groups, respectively (p=0.01), in contrast, the corresponding rates of non-cancer-related death were 4.72% (95% CI=1.40-11.10%) and 9.44% (95% CI=4.50-16.50%), respectively (p=0.18). These results indicate that survival of patients with consolidation-dominant part-solid adenocarcinoma is poor due to a higher rate of lung cancer death.

Conclusion: The radiographical consolidation tumor size may affect overall survival and possibly reflect tumor growth activity, being consistent with 8th edition of the TNM classification in that larger consolidation tumor size significantly correlates with poor survival.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信